BioCatalyst

icovamenib 100mg — catalyst calendar

1 verified catalyst event(s) referencing icovamenib 100mg, each linked to its official source. Verified as of 2026-10-30.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Ach
Phase 2 · Type 2 Diabetes
 BMEA Biomea Fusion, Inc. icovamenib 100mg ClinicalTrials.gov ↗
✓ Source-checked 2026-10-30
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.